SEC 13F Intelligence

Capital World Investors / REGN

Capital World Investors’s Regeneron Pharmaceuticals Position

Does Capital World Investors own Regeneron Pharmaceuticals (REGN)? Yes — 1.42M shares worth $1.1B (+0.15% of its 13F portfolio) as of Q1 2026, up from 1.40M shares the prior filed quarter.

Position Value
$1.1B
Q1 2026
Shares
1.42M
% of Portfolio
+0.15%
Quarters Held
26
currently held

Position History REGN

Reported value by quarter
Q4 ’19: $3.1BQ4 ’19Q1 ’20: $3.5BQ2 ’20: $4.3BQ3 ’20: $3.7BQ4 ’20: $3.4BQ4 ’20Q1 ’21: $2.9BQ2 ’21: $3.0BQ3 ’21: $3.2BQ4 ’21: $3.4BQ4 ’21Q1 ’22: $4.2BQ2 ’22: $3.7BQ3 ’22: $4.3BQ4 ’22: $4.5BQ4 ’22Q1 ’23: $4.8BQ2 ’23: $4.0BQ3 ’23: $4.2BQ4 ’23: $4.5BQ4 ’23Q1 ’24: $4.5BQ2 ’24: $4.9BQ3 ’24: $4.5BQ4 ’24: $2.0BQ4 ’24Q1 ’25: $1.2BQ2 ’25: $1.0BQ3 ’25: $1.1BQ4 ’25: $1.1BQ4 ’25Q1 ’26: $1.1Bfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.42M$1.1B+0.15%
Q4 20251.40M$1.1B+0.15%
Q3 20252.00M$1.1B+0.15%
Q2 20251.97M$1.0B+0.15%
Q1 20251.94M$1.2B+0.20%
Q4 20242.78M$2.0B+0.30%
Q3 20244.30M$4.5B+0.70%
Q2 20244.64M$4.9B+0.79%
Q1 20244.65M$4.5B+0.74%
Q4 20235.13M$4.5B+0.80%
Q3 20235.11M$4.2B+0.83%
Q2 20235.55M$4.0B+0.77%
Q1 20235.83M$4.8B+0.99%
Q4 20226.24M$4.5B+0.96%
Q3 20226.23M$4.3B+0.96%
Q2 20226.23M$3.7B+0.78%
Q1 20225.95M$4.2B+0.72%
Q4 20215.32M$3.4B+0.53%
Q3 20215.32M$3.2B+0.55%
Q2 20215.31M$3.0B+0.50%
Q1 20216.18M$2.9B+0.54%
Q4 20206.95M$3.4B+0.65%
Q3 20206.64M$3.7B+0.81%
Q2 20206.94M$4.3B+1.05%
Q1 20207.13M$3.5B+1.01%
Q4 20198.33M$3.1B+0.70%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Capital World Investors’s full portfolio or all institutional holders of REGN.